Covid vaccine: Serum Institute says India trials will continue after partner AstraZeneca halts trials in UK

1 329

The Oxford vaccine consists of two doses and the second dose is taken 28 days after the first shot. Vaccine maker Serum Institute of India on Wednesday said the ongoing clinical trials in India for the Covid-19 vaccine, developed by University of Oxford and AstraZeneca, will continue and not be affected by AstraZeneca’s announcement of … Read more